Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Global Allergy And Immunology Market Outlook
4.1. Market Size & Forecast
4.1.1. By Value
4.2. Market Share & Forecast
4.2.1. By Treatment Type (Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy (SLIT), Tablets, Drops)
4.2.2. By Allergy Type (Allergic Rhinitis, Allergic Asthma, Other Allergies)
4.2.3. By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)
4.2.4. By Region
4.2.5. By Company (2022)
4.3. Market Map
4.3.1. By Treatment Type
4.3.2. By Allergy Type
4.3.3. By Distribution Channel
4.3.4. By Region
5. Asia Pacific Allergy And Immunology Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Treatment Type
5.2.2. By Allergy Type
5.2.3. By Distribution Channel
5.2.4. By Country
5.3. Asia Pacific: Country Analysis
5.3.1. China Allergy And Immunology Market Outlook
5.3.1.1. Market Size & Forecast
5.3.1.1.1. By Value
5.3.1.2. Market Share & Forecast
5.3.1.2.1. By Treatment Type
5.3.1.2.2. By Allergy Type
5.3.1.2.3. By Distribution Channel
5.3.2. India Allergy And Immunology Market Outlook
5.3.2.1. Market Size & Forecast
5.3.2.1.1. By Value
5.3.2.2. Market Share & Forecast
5.3.2.2.1. By Treatment Type
5.3.2.2.2. By Allergy Type
5.3.2.2.3. By Distribution Channel
5.3.3. Australia Allergy And Immunology Market Outlook
5.3.3.1. Market Size & Forecast
5.3.3.1.1. By Value
5.3.3.2. Market Share & Forecast
5.3.3.2.1. By Treatment Type
5.3.3.2.2. By Allergy Type
5.3.3.2.3. By Distribution Channel
5.3.4. Japan Allergy And Immunology Market Outlook
5.3.4.1. Market Size & Forecast
5.3.4.1.1. By Value
5.3.4.2. Market Share & Forecast
5.3.4.2.1. By Treatment Type
5.3.4.2.2. By Allergy Type
5.3.4.2.3. By Distribution Channel
5.3.5. South Korea Allergy And Immunology Market Outlook
5.3.5.1. Market Size & Forecast
5.3.5.1.1. By Value
5.3.5.2. Market Share & Forecast
5.3.5.2.1. By Treatment Type
5.3.5.2.2. By Allergy Type
5.3.5.2.3. By Distribution Channel
6. Europe Allergy And Immunology Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Treatment Type
6.2.2. By Allergy Type
6.2.3. By Distribution Channel
6.2.4. By Country
6.3. Europe: Country Analysis
6.3.1. France Allergy And Immunology Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Treatment Type
6.3.1.2.2. By Allergy Type
6.3.1.2.3. By Distribution Channel
6.3.2. Germany Allergy And Immunology Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Treatment Type
6.3.2.2.2. By Allergy Type
6.3.2.2.3. By Distribution Channel
6.3.3. Spain Allergy And Immunology Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Treatment Type
6.3.3.2.2. By Allergy Type
6.3.3.2.3. By Distribution Channel
6.3.4. Italy Allergy And Immunology Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Treatment Type
6.3.4.2.2. By Allergy Type
6.3.4.2.3. By Distribution Channel
6.3.5. United Kingdom Allergy And Immunology Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Treatment Type
6.3.5.2.2. By Allergy Type
6.3.5.2.3. By Distribution Channel
7. North America Allergy And Immunology Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Treatment Type
7.2.2. By Allergy Type
7.2.3. By Distribution Channel
7.2.4. By Country
7.3. North America: Country Analysis
7.3.1. United States Allergy And Immunology Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Treatment Type
7.3.1.2.2. By Allergy Type
7.3.1.2.3. By Distribution Channel
7.3.2. Mexico Allergy And Immunology Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Treatment Type
7.3.2.2.2. By Allergy Type
7.3.2.2.3. By Distribution Channel
7.3.3. Canada Allergy And Immunology Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Treatment Type
7.3.3.2.2. By Allergy Type
7.3.3.2.3. By Distribution Channel
8. South America Allergy And Immunology Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Treatment Type
8.2.2. By Allergy Type
8.2.3. By Distribution Channel
8.2.4. By Country
8.3. South America: Country Analysis
8.3.1. Brazil Allergy And Immunology Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Treatment Type
8.3.1.2.2. By Allergy Type
8.3.1.2.3. By Distribution Channel
8.3.2. Argentina Allergy And Immunology Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Treatment Type
8.3.2.2.2. By Allergy Type
8.3.2.2.3. By Distribution Channel
8.3.3. Colombia Allergy And Immunology Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Treatment Type
8.3.3.2.2. By Allergy Type
8.3.3.2.3. By Distribution Channel
9. Middle East and Africa Allergy And Immunology Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Treatment Type
9.2.2. By Allergy Type
9.2.3. By Distribution Channel
9.2.4. By Country
9.3. MEA: Country Analysis
9.3.1. South Africa Allergy And Immunology Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Treatment Type
9.3.1.2.2. By Allergy Type
9.3.1.2.3. By Distribution Channel
9.3.2. Saudi Arabia Allergy And Immunology Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Treatment Type
9.3.2.2.2. By Allergy Type
9.3.2.2.3. By Distribution Channel
9.3.3. UAE Allergy And Immunology Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Treatment Type
9.3.3.2.2. By Allergy Type
9.3.3.2.3. By Distribution Channel
9.3.4. Egypt Allergy And Immunology Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Treatment Type
9.3.4.2.2. By Allergy Type
9.3.4.2.3. By Distribution Channel
10. Market Dynamics
10.1. Drivers
10.2. Challenges
11. Market Trends & Developments
11.1. Recent Developments
11.2. Allergy Type Launches
11.3. Mergers & Acquisitions
12. Global Allergy And Immunology Market: SWOT Analysis
13. Porter?s Five Forces Analysis
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Product
14. Competitive Landscape
14.1. ALK-Abello A/S
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Product & Services
14.1.4. Current Capacity Analysis
14.1.5. Financials (In case of listed)
14.1.6. Recent Developments
14.1.7. SWOT Analysis
14.2. Teva Pharmaceutical Industries
14.3. AbbVie Inc.
14.4. Stallergenes Greer PLC
14.5. Allergy Therapeutics
14.6. Sanofi SA
14.7. Anacor Pharmaceuticals Inc.
14.8. Novartis International AG
14.9. AstraZeneca
14.10. Merck KGaA
14.11. F. Hoffmann-La Roche Ltd
14.12. Johnson & Johnson
14.13. GlaxoSmithKline PLC
14.14. Mylan N.V.
15. Strategic Recommendations
16. About Us & Disclaimer